President Trump has advanced his Great Healthcare Plan through multiple 2026 announcements, emphasizing Most-Favored-Nation drug pricing agreements with major manufacturers, the TrumpRx platform for direct consumer discounts, and redirection of Affordable Care Act subsidies straight to enrollees rather than insurers. Recent administration data showed prescription drug prices recording their steepest annual decline since 1963, with cuts of 50-90% or more on select medications including GLP-1s. In his late-August State of the Union address and prior remarks, Trump repeatedly highlighted these results, criticized the ACA as benefiting insurers, and urged Congress to codify the framework for further premium reductions and price transparency. Trader focus centers on recurring phrasing around these elements, historical price comparisons, and calls for immediate legislative action amid ongoing implementation.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedR&D / Research and Development
44%
Neurocrine
27%
Failing Nation / Failing Country
47%
Protester
33%
Madrigal
31%
Psychiatric / Psychedelic
18%
London
47%
Middleman / Middle Man
70%
Rare / Chronic
39%
Obama
60%
Kharg / Island
53%
Minesweeper / Mine Dropper
17%
AI / Artificial Intelligence
37%
Venezuela
63%
Mental / Mentally
31%
-No Qualifying Event-
3%
$4,375 Vol.
R&D / Research and Development
44%
Neurocrine
27%
Failing Nation / Failing Country
47%
Protester
33%
Madrigal
31%
Psychiatric / Psychedelic
18%
London
47%
Middleman / Middle Man
70%
Rare / Chronic
39%
Obama
60%
Kharg / Island
53%
Minesweeper / Mine Dropper
17%
AI / Artificial Intelligence
37%
Venezuela
63%
Mental / Mentally
31%
-No Qualifying Event-
3%
This market will resolve to "Yes" if Donald Trump says the listed term during the specified appearance. Otherwise, the market will resolve to "No".
This market is explicitly about Trump's announcement on healthcare affordability in the Oval Office on August 31, 2026 (https://rollcall.com/factbase/trump/calendar/). Speeches, events, or comments that occur outside of the named, scheduled event will not qualify toward this market's resolution.
If this event is definitively cancelled, or otherwise is not available by September 1, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio/video of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Mentions/Event+Mentions+Contract+DeFi.pdf
Market Opened: Aug 31, 2026, 11:03 AM ET
Resolver
0x65070BE91...This market will resolve to "Yes" if Donald Trump says the listed term during the specified appearance. Otherwise, the market will resolve to "No".
This market is explicitly about Trump's announcement on healthcare affordability in the Oval Office on August 31, 2026 (https://rollcall.com/factbase/trump/calendar/). Speeches, events, or comments that occur outside of the named, scheduled event will not qualify toward this market's resolution.
If this event is definitively cancelled, or otherwise is not available by September 1, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio/video of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Mentions/Event+Mentions+Contract+DeFi.pdf
Resolver
0x65070BE91...President Trump has advanced his Great Healthcare Plan through multiple 2026 announcements, emphasizing Most-Favored-Nation drug pricing agreements with major manufacturers, the TrumpRx platform for direct consumer discounts, and redirection of Affordable Care Act subsidies straight to enrollees rather than insurers. Recent administration data showed prescription drug prices recording their steepest annual decline since 1963, with cuts of 50-90% or more on select medications including GLP-1s. In his late-August State of the Union address and prior remarks, Trump repeatedly highlighted these results, criticized the ACA as benefiting insurers, and urged Congress to codify the framework for further premium reductions and price transparency. Trader focus centers on recurring phrasing around these elements, historical price comparisons, and calls for immediate legislative action amid ongoing implementation.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated


Beware of external links.
Beware of external links.
Frequently Asked Questions